Trial intelligence / Profile preview

TAP block combined with oxycodone for half effective concentration of ropivacaine in laparoscopic hysterectomy

ChiCTR2400081551Phase 4Recruiting

Sponsor
Medical Ethics Committee of Yancheng First People's Hospital
Start
Mar 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Medical Ethics Committee of Yancheng First People's Hospital. Primary endpoints: Perioperative conditions and Pain conditions. Started Mar 2024; status: recruiting.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR2400081551.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400081551.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call